EUVIMEDEUVIMED entdecken
Netzwerk-MetaanalyseÜbersichtsarbeitOpen Access · CC BY 4.0

Comparative Efficacy of GLP‐1 Receptor Agonists, Exercise, and Their Combination on Body Composition and Glucolipid Metabolism in Adults With Overweight or Obesity: A Network Meta‐Analysis of Randomized Controlled Trials

Matteo Vandoni, Alessandro Gatti iD, Virginia Rossi, Matteo Giuriato iD, Vittoria Carnevale Pellino, Gianvincenzo Zuccotti, Valeria Calcaterra iD

Obesity Reviews · 2026

DOI: 10.1111/obr.70189 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Obesity Reviews, 2026. Verfasst von Matteo Vandoni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Adapted Motor Activity (LAMA) - Department of Public Health, Experimental Medicine and Forensic Science, University of Pavia, Pavia, It…. Hauptthemen laut MEDLINE: Body Composition, Obesity, Overweight, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The paper aims to assess the effects of GLP‐1 RAs, structured exercise, and their combination on body composition and cardiometabolic outcomes in adults with overweight or obesity.

Methods

PubMed, Web of Science, Scopus, and EBSCO were searched through April 2026 for English‐language RCTs using terms related to obesity, GLP‐1 RAs, exercise, and glucolipid metabolism outcomes. We included RCTs of adults (18–65 years, BMI ≥ 25 kg/m 2 ) without major comorbidities, except for type 2 diabetes, testing GLP‐1 RAs, structured exercise, or both. Of 2508 screened articles, nine studies comprising 1009 participants met eligibility criteria. Participants included 589F/420M, with a weighted mean age of 43.8 ± 12.2 years and weighted mean BMI of 32.6 ± 3.0 kg/m 2 . Risk of bias was assessed using RoB 2. A frequentist random‐effects model calculated SMDs. Primary outcomes were changes in body weight, waist‐to‐hip ratio, and fat mass. Secondary outcomes included fasting glucose, HOMA‐IR, triglycerides, LDL‐C, and HDL‐ C. Meta ‐regression assessed weight loss as a predictor of metabolic outcomes.

Results

The combination of GLP‐1 receptor agonists and exercise was associated with the greatest effects on weight (SMD −1.04; 95% CI −1.24 to −0.83), fat mass (SMD −1.01; 95% CI −1.27 to −0.75), and waist‐to‐hip ratio (SMD −0.55; 95% CI −0.91 to −0.18) compared with placebo. For fasting glucose, the SMD was −0.49 (95% CI −1.52 to 0.55); for HOMA‐IR, −0.59 (95% CI −0.89 to −0.29). For lipid outcomes, no statistically significant differences were observed for triglycerides or LDL‐C, whereas HDL‐C increased compared with placebo (SMD 0.32; 95% CI 0.04 to 0.61). Confidence in the evidence was high for body weight and fat mass, moderate for waist‐to‐height ratio and most lipid outcomes, and very low for fasting glucose.

Conclusions

Combined GLP‐1 RA and structured exercise interventions improved weight, insulin sensitivity, and selected lipid parameters more than monotherapies or placebo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Body CompositionObesityOverweightGlucagon-Like Peptide-1 Receptor AgonistsExerciseLipid MetabolismHumansRandomized Controlled Trials as TopicAdultBlood Glucose

Stichwörter der Autor:innen

GLP‐1cardiometabolicexerciseobesityoverweightweight

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsBlood Glucose

Autor:innen und Institutionen

  • Laboratory of Adapted Motor Activity (LAMA) - Department of Public Health, Experimental Medicine and Forensic Science, University of Pavia, Pavia, Italy.
  • National PhD Programme in One Health Approaches to Infectious Diseases and Life Science Research, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
  • Pediatric Department, "Vittore Buzzi" Children's Hospital, Milan, Italy.
  • Department of Biomedical and Clinical Science, University of Milano, Milan, Italy.
  • Department of Education and Sport Sciences, Pegaso University, Naples, Italy.
  • Pediatric and Adolescent Unit, Department of Internal Medicine, University of Pavia, Pavia, Italy.

ORCID-Profile: Alessandro Gatti, Matteo Giuriato, Valeria Calcaterra

Zitieren

APA

Vandoni, M., Gatti, A., Rossi, V., Giuriato, M., Pellino, V. C., Zuccotti, G., & Calcaterra, V. (2026). Comparative Efficacy of GLP‐1 Receptor Agonists, Exercise, and Their Combination on Body Composition and Glucolipid Metabolism in Adults With Overweight or Obesity: A Network Meta‐Analysis of Randomized Controlled Trials. Obesity Reviews. https://doi.org/10.1111/obr.70189

Vancouver

Vandoni M, Gatti A, Rossi V, Giuriato M, Pellino VC, Zuccotti G, et al. Comparative Efficacy of GLP‐1 Receptor Agonists, Exercise, and Their Combination on Body Composition and Glucolipid Metabolism in Adults With Overweight or Obesity: A Network Meta‐Analysis of Randomized Controlled Trials. Obesity Reviews. 2026. doi:10.1111/obr.70189

BibTeX
@article{Vandoni2026,
  author = {Vandoni, Matteo and Gatti, Alessandro and Rossi, Virginia and Giuriato, Matteo and Pellino, Vittoria Carnevale and Zuccotti, Gianvincenzo and Calcaterra, Valeria},
  title = {Comparative Efficacy of GLP‐1 Receptor Agonists, Exercise, and Their Combination on Body Composition and Glucolipid Metabolism in Adults With Overweight or Obesity: A Network Meta‐Analysis of Randomized Controlled Trials},
  journal = {Obesity Reviews},
  year = {2026},
  doi = {10.1111/obr.70189}
}
Kostenlos starten →